The approval of Lipfendra gives Merck the first oral PCSK9 cholesterol-lowering drug in the US market, strengthening its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results